Paid Clinical Trials in Meridian, ID
As of June 2026, 109 paid clinical trials are recruiting in Meridian, Idaho. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Meridian offers studies at sites including Saint Luke's Cancer Institute - Meridian for conditions such as Acute Myeloid Leukemia, Obesity, Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Meridian
Filter results
0 clinical trials
·Clear filters·↓ Download CSVAbout research studies in Meridian
Meridian has approximately 109 recruiting research studies across a wide range of therapeutic areas. Idaho hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Meridian
Researchers run research studies in Meridian, ID at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Luke's Cancer Institute - Meridian | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm | 70 |
| Idaho Urologic Institute-Meridian | Malignant Solid Neoplasm, Stage IIIB Lung Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8 | 38 |
| Velocity Clinical Research - Boise | Diabetic Peripheral Neuropathic Pain, Atherosclerotic Cardiovascular Disease, COPD | 8 |
| Solaris Clinical Research | Obesity, Cardiovascular Disease, Overweight | 3 |
| St. Luke's Idaho Cardiology Associates | Heart Failure, Acute Myocardial Infarction (AMI), Cardiovascular Risk | 3 |
| Ada West Research | Atopic Dermatitis, Pyoderma Gangrenosum | 2 |
| Boise Kidney & Hypertension Institute | Diabetic Kidney Disease, Chronic Kidney Disease, Chronic Kidney Diseases | 2 |
| CARE Institute - High Desert | Atherosclerosis, Atherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Diseases | 2 |
| Velocity Clinical Research, Boise | Influenza, Respiratory Syncytial Virus Infections | 2 |
| Ada West Research, LLC | Atopic, Atopic Dermatitis, Dermatitis | 1 |
| Care Institute- High Desert | Diabetes Mellitus, Type 2, Metabolic Syndrome, PreDiabetes | 1 |
| High Desert Heart and Vascular | Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Obesity | 1 |
| High Desert Heart and Vascular PLLC | Heart Failure, Obesity | 1 |
| Idaho Physical Medicine and Rehabilitation | Lumbar Spinal Stenosis | 1 |
| Idaho Urologic Institute | Prostate Cancer Detection | 1 |
| Meridian | Endometriosis, Uterine Fibroids | 1 |
| St Luke's Clinic - Neurology | Menstrual Migraine | 1 |
| St Lukes Idaho Cardiology Associates | Cardiovascular Disease | 1 |
| St. Luke's Idaho Pulmonary Associates - Meridian Clinic | OSA | 1 |
| The Allergy Group-Meridian Clinic | Chronic Spontaneous Urticaria (CSU) | 1 |
| Velocity Clinical Research | PTSD - Post Traumatic Stress Disorder | 1 |
Active & Upcoming Studies in Meridian (2026)
Recruiting trials in Meridian grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (66 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix · Sequenom, Inc.
Diabetes & metabolic (6 active studies)
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight · Phase 3 · Novo Nordisk A/S
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Neurology & pain (6 active studies)
- A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine · Phase 3 · Pfizer
- Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy · Phase 2 · Vertex Pharmaceuticals Incorporated
Vaccines (3 active studies)
- A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults · Phase 3 · ModernaTX, Inc.
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cardiovascular (3 active studies)
Mental health & behavior (1 active study)
- REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool · Phase 3 · Senseye, Inc.
Common conditions studied in Meridian
- Acute Myeloid Leukemia (6 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Obesity (5 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Malignant Solid Neoplasm (4 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage IIIB Lung Cancer AJCC v8 (4 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Stage IVB Prostate Cancer AJCC v8 (4 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
Leading research sponsors in Meridian
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- ECOG-ACRIN Cancer Research Group
- NRG Oncology
Local regulations and guidelines
Clinical trials in Idaho are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Idaho research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Meridian. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Meridian
Hipa.ai aggregates every recruiting study in Meridian from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Meridian?
There are approximately 109 recruiting clinical trials in Meridian, Idaho listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Meridian pay participants?
Most recruiting trials in Meridian compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Meridian?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Meridian?
The most common conditions under active study in Meridian include Acute Myeloid Leukemia (6), Obesity (5), Anatomic Stage II Breast Cancer AJCC v8 (4), Malignant Solid Neoplasm (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Meridian?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Meridian on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Meridian?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Meridian?
Recruiting research sites in Meridian include Saint Luke's Cancer Institute - Meridian, Idaho Urologic Institute-Meridian, Velocity Clinical Research - Boise, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Meridian right now?
The largest active categories in Meridian are Cancer & tumors (66), Diabetes & metabolic (6), Neurology & pain (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.